| 2441 |
ALYNNI |
Alectinib 150 mg |
CAPSULE |
BOTTLE |
non - small cell lung cancer (NSCLC) |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 0811/19 |
07-SEP-2022 |
06-SEP-2025 |
View |
| 2442 |
AVABOPA |
AVATROMBOPAG 20 MG |
FILM COATED TABLET |
BOTTLE |
IN ADULT WITH CHRONIC LIVER DISEASE TO TREAT LOW PLATELET COUNT BEFORE HAVEING A MEDICAL PROCEDURE WHERE THERE IS A RISK OF BLEEDING |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 I 0990/23 |
26-JUL-2023 |
25-JUL-2026 |
View |
| 2443 |
AVABOPA |
AVATROMBOPAG 20 MG |
FILM COATED TABLET |
BOTTLE |
USED IN ADULT WITH CHRONIC LIVER DISEASE TO TREAT LOW PLATELET COUNT BEFORE HAVING A MEDICAL PROCEDURE WHERE IS THE RISK OF BLEEDING |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0990/23 |
26-JUL-2023 |
25-JUL-2026 |
View |
| 2444 |
BEIGANI |
Brigatinib 90 mg |
FILM-COATED TABLETS |
BOTTLE |
non - small cell lung cancer (NSCLC) |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 0809/19 |
07-SEP-2022 |
06-SEP-2025 |
View |
| 2445 |
BOLEMIDE |
POMALIDOMIDE 2 MG |
CAPSULE |
BOTTLE |
MULTIPLE MYELOMA IS A CANCER OF THE PLASMA CELLS IN BONE MARROW |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 0714/16 |
09-Oct-2023 |
08-Oct-2026 |
View |
| 2446 |
BOLEMIDE |
POMALIDOMIDE 4 MG |
CAPSULE |
BOTTLE |
MULTIPLE MYELOMA IS A CANCER OF THE PLASMA CELLS IN BONE MARROW. |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 0712/16 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 2447 |
CABONNI |
CABOZANTINIB 20 MG |
CAPSULE |
Bottle |
TO TREAT MEDULLARY THYROID CANCER, A RARE TYPE OF TYPHOID CANCER THAT CANNOT BE REMOVED BY SURGERY OR THAT HAS SPRERAD TO OTHER PARTS OF THE BODY |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 0842/21 |
21-AUG-2024 |
20-AUG-2027 |
View |
| 2448 |
DAPOCITIN |
DAPOXETINE 30 MG |
FILM COATED TABLET |
BOTTLE |
USED TO TREAT PREMAJURE EJACULATION IN MEN BETWEEN 18 AND 64 YEARS OLD |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.,LTD |
LAO PDR |
CERTIFICATE RELEASED |
09 I 0924/22 |
07-OCT-2022 |
06-OCT-2025 |
View |
| 2449 |
ELANFINOR |
ELAFIBRANOR 80 MG |
FILM-COATED TABLETS |
BOTTLE |
used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 1354/25 |
27-MAY-2025 |
26-MAY-2030 |
View |
| 2450 |
ELOBOPA |
ELTROBOPAG 25 MG |
TABLET |
Bottle |
TREATMENT OF BLEEDING DISORDER CALLED IMMUNE THROBOCYTOPENIC PURPURA IN PATIENTS AGED 1 YEAR AND ABOVE AND ALSO TREATMENT OF LOW PLATELET THROBOCYTOPENIAL IN ADULT.. |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
10 L 0731/17 |
07-AUG-2024 |
06-AUG-2027 |
View |
